Ingevity (NYSE:NGVT)‘s stock had its “outperform” rating reaffirmed by stock analysts at Rowe in a report issued on Thursday. They currently have a $90.00 price objective on the stock, up from their prior price objective of $80.00. Rowe’s price target would indicate a potential upside of 13.84% from the company’s current price.

Other equities analysts have also issued reports about the stock. KeyCorp reiterated a “buy” rating and issued a $75.00 price target (up from $70.00) on shares of Ingevity in a research note on Thursday, October 5th. Zacks Investment Research upgraded shares of Ingevity from a “hold” rating to a “buy” rating and set a $73.00 price target on the stock in a research note on Wednesday, October 4th. Loop Capital started coverage on shares of Ingevity in a research note on Thursday, September 28th. They issued a “buy” rating and a $73.00 price target on the stock. Jefferies Group set a $71.00 price target on shares of Ingevity and gave the company a “buy” rating in a research note on Thursday, August 24th. Finally, BidaskClub upgraded shares of Ingevity from a “hold” rating to a “buy” rating in a research note on Saturday, November 4th. Eight analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and a consensus price target of $75.57.

Shares of Ingevity (NYSE:NGVT) opened at $79.06 on Thursday. The firm has a market cap of $3,351.97, a P/E ratio of 32.22, a P/E/G ratio of 2.66 and a beta of 1.78. Ingevity has a 1-year low of $48.74 and a 1-year high of $79.87. The company has a quick ratio of 1.34, a current ratio of 2.36 and a debt-to-equity ratio of 1.92.

Ingevity (NYSE:NGVT) last issued its earnings results on Wednesday, November 1st. The company reported $0.86 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.75 by $0.11. The firm had revenue of $264.10 million for the quarter, compared to analysts’ expectations of $260.88 million. Ingevity had a net margin of 9.86% and a return on equity of 58.14%. The firm’s revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.64 earnings per share. equities analysts forecast that Ingevity will post 2.49 EPS for the current year.

A number of institutional investors have recently made changes to their positions in NGVT. Royal Bank of Canada grew its position in shares of Ingevity by 169.9% during the second quarter. Royal Bank of Canada now owns 535,159 shares of the company’s stock worth $30,718,000 after acquiring an additional 336,897 shares during the last quarter. Marshall Wace North America L.P. grew its position in shares of Ingevity by 4,456.0% during the second quarter. Marshall Wace North America L.P. now owns 263,974 shares of the company’s stock worth $15,046,000 after acquiring an additional 258,180 shares during the last quarter. Wells Fargo & Company MN grew its position in shares of Ingevity by 320.0% during the second quarter. Wells Fargo & Company MN now owns 302,614 shares of the company’s stock worth $17,370,000 after acquiring an additional 230,558 shares during the last quarter. TPG Group Holdings SBS Advisors Inc. grew its position in shares of Ingevity by 34.3% during the second quarter. TPG Group Holdings SBS Advisors Inc. now owns 887,324 shares of the company’s stock worth $50,932,000 after acquiring an additional 226,830 shares during the last quarter. Finally, Chilton Investment Co. LLC grew its position in shares of Ingevity by 26.3% during the second quarter. Chilton Investment Co. LLC now owns 1,066,649 shares of the company’s stock worth $61,226,000 after acquiring an additional 221,932 shares during the last quarter. Institutional investors own 91.41% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Ingevity (NGVT) Stock Rating Reaffirmed by Rowe” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/12/02/ingevity-ngvt-stock-rating-reaffirmed-by-rowe.html.

About Ingevity

Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals.

Analyst Recommendations for Ingevity (NYSE:NGVT)

Receive News & Stock Ratings for Ingevity Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity Corporation and related stocks with our FREE daily email newsletter.